Stock market news

TNS Energy Kuban

TNS Energy Kuban's RAS net profit for 6 months of 2024 amounted to ₽1.92 billion, up 17.1% from ₽1.64 billion in the previous year. Revenue increased 2.8% to ₽39.92 billion against ₽38.85 billion a year earlier.

TNS Energy Mari El

TNS Energy Mari El's RAS net profit for 6 months of 2024 amounted to ₽0.831 billion, down 30.8% from ₽1.2 billion in the previous year. Revenue increased 4.1% to ₽5.1 billion compared to ₽4.9 billion a year earlier.

TNS Energo Yaroslavl

TNS Energy Yaroslavl's RAS net profit for 6 months of 2024 amounted to ₽179.29 million, down 2.8 times from ₽510.93 million in the previous year. Revenue rose 3.9% to ₽11.25 billion against ₽10.83 billion a year earlier.

Sovcombank

Sovcombank's RAS net profit for 6 months of 2024 amounted to ₽27.84 billion, down 2 times from ₽58.56 billion in the previous year. Net interest income declined 0.1% to ₽59.95 billion from ₽59.98 billion a year earlier.

Kuznetskiy Bank

Bank Kuznetsky's net profit under RAS for 6 months of 2024 amounted to ₽61.7 million, down 2.4 times from ₽145.29 million in the previous year. Net interest income rose 32% to ₽258.74 million against ₽196.02 million a year earlier.

Moscow City Telephone Network

MGTS' RAS net profit for 6 months of 2024 amounted to ₽11.48 billion, up 25.2% from ₽9.17 billion in the previous year. Revenue rose 1% to ₽21.36 billion against ₽21.14 billion a year earlier.

Surgutneftegaz

Surgutneftegaz's RAS net profit for 6 months of 2024 amounted to ₽139.89 billion, down 6 times from ₽846.57 billion in the previous year. Revenue the company chose not to disclose.

SPB Exchange

SPB Exchange's RAS loss for 6 months of 2024 amounted to ₽657.58 million, up 24.4% from ₽528.75 million in the previous year. Trading and investment income fell 17% to ₽218.56 million against ₽263.26 million a year earlier. Commission income declined 7 times to ₽41.38 million.

EL5-Energo

EL5-Energo's RAS net profit for 6 months of 2024 amounted to ₽2.4 billion, up 31.1% from ₽1.83 billion in the previous year. Revenue rose 14.2% to ₽29 billion versus ₽25.4 billion a year earlier.

Pharmsynthesis

Pharmsintez's RAS loss for 6 months of 2024 amounted to ₽74.31 million, down 46.2% from ₽138 million in the previous year. Revenue declined 19.8% to ₽102.24 million from ₽127.53 million a year earlier.